Adam Garsa, MD

Associate Professor Of Clinical Radiation Oncology

Image of Adam Garsa, MD
Is this your profile? Click to edit

Overview

Dr.Garsa is an Assistant Professor of Clinical Radiation Oncology at USC Norris Cancer Hospital and USC + Los Angeles County Medical Center. He joined USC in June 2017.

Dr. Garsa graduated with honors from Washington University in St. Louis with a Bachelor of Arts degree in biology. He received his medical degree from the University of Pittsburgh School of Medicine, and completed his residency in radiation oncology at Washington University School of Medicine. In addition, he competed a CNS radiation oncology fellowship in at the University of California San Francisco.

After completing his clinical fellowship, Dr. Garsa was on the faculty at UCSF specializing in the treatment of head and neck, CNS, skin, and lung cancers. Dr. Garsa has presented and published multiple studies investigating advanced imaging technologies and radiation therapy techniques to allow for maximal therapeutic effect while minimizing treatment side effects.

Clinical Expertise: Head and Neck, CNS, Skin Cancer, and SBRT

Publications

  • Modern Radiosurgery Approaches for Brain Metastases. Cancer J. 2026 Jan-Feb 01; 32(1).. View in PubMed
  • ACR-ARS Practice Parameter for Image-Guided Radiation Therapy (IGRT). Am J Clin Oncol. 2025 11 01; 48(11):529-539.. View in PubMed
  • Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2023 07 01; 116(3):533-543.. View in PubMed
  • Radiation Therapy for Brain Metastases: A Systematic Review. Pract Radiat Oncol. 2021 Sep-Oct; 11(5):354-365.. View in PubMed
  • Use of Salvage Surgery or Stereotactic Radiosurgery for Multiply Recurrent Skull Base Chordomas: A Single-Institution Experience and Review of the Literature. J Neurol Surg B Skull Base. 2021 Apr; 82(2):161-174.. View in PubMed
  • Bevacizumab is more effective in nasopharyngeal carcinoma patients with lower maximum radiation dose to the temporal lobe. Chin Clin Oncol. 2019 Oct; 8(S1):S20.. View in PubMed
  • Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging. Head Neck. 2018 10; 40(10):2280-2287.. View in PubMed
  • Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy. J Appl Clin Med Phys. 2018 Jul; 19(4):48-57.. View in PubMed
  • Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy. Head Neck. 2018 07; 40(7):1406-1414.. View in PubMed
  • Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension. Laryngoscope. 2018 10; 128(10):2226-2233.. View in PubMed